Niramai Health Analytix’s Post

Countdown is ticking....only 8 days until Science & Engineering Health Technologies Alliance (SEHTA)'s 2024 International MedTech Expo & Conference which takes place this year on Friday 1st November in London, come along to meet with Check4Cancer who are exhibiting for the first time. This is not just another event; it's a fantastic opportunity to gather insights and discuss the impacts on MedTech, funding, and commissioning in the coming year. With an expert team from across the industry, you can expect valuable discussions around pressing issues and exciting developments in healthcare. Check4Cancer (C4C) is an award-winning early cancer detection company that provides tech-enabled solutions for cancer risk assessment, prevention, screening & diagnostics to insured, corporate & self-pay markets in UK. In 2021, C4C launched an online cancer risk questionnaire (MyCancerRisk) that underpins a risk-stratified cancer screening programme for insured or corporate clients. Since 2022, Check4Cancer has worked with the University of Essex to build an AI model for skin lesion classification using C4C’s large database of images and clinical metadata. A skin cancer app to allow high quality skin images to be taken at home will be launched in September 2024. 🔍 ONLY 8 DAYS TO GO!! So don't delay to connect with delegates from MedTech/Life Sciences SMEs, Clinicians, NHS Providers, Academics & Service Providers throughout the day. 🌟 Delegate fee starts from £400+VATpp & #NHS staff go FREE! (Ticket includes full day catering, access to expo & conference) For more info & to register visit http://www.bit.ly/47ChcRO #medtech #diagnostics #meddevice #digitalhealth #lifesciences #medicaldevices #innovators #startups #academics #clinicians #healthcare #healthtech #SMEs #AI #IVD #regulatory

With the AdvaMed conference just two weeks away, we’re excited to showcase how our expertise in women’s health research can elevate your upcoming studies. Our proven experience in this area sets us apart, offering valuable insights for your projects. 🚀 Women’s Health Expertise: TTi Health Research & Economics is renowned for its work in women’s health, tackling unique challenges and opportunities within this field. For instance, our meta-analysis of local invasive breast cancer recurrence after electron intraoperative radiotherapy demonstrated significant insights into recurrence rates, supporting the use of this innovative treatment in early-stage breast cancer care. This experience equips us to navigate regulatory landscapes and market needs with confidence. 🔍 Integrated Approach: We integrate reimbursement and health economics directly into our research strategies. Our work on a study examining the risk of structural birth defects associated with first trimester ondansetron exposure showcases our commitment to rigorous methodologies. By addressing limitations of prior studies and utilizing large population data, we ensure your studies meet payer requirements and market expectations. This comprehensive approach accelerates the research process and enhances its relevance. 💡 Enhanced Results: By leveraging our deep industry knowledge and integrated strategies, we optimize your market positioning and accelerate research outcomes. For example, our collaboration with the CDC on a pilot study addressing women’s health issues in immigrant and refugee populations highlights our ability to create tailored solutions that address specific health concerns. We help you achieve high-quality results that align with your business and patient goals, making a meaningful impact in women’s health. Women's health is near and dear to us. Dr. Zambelli-Weiner an Fernanda Nusbaum are available to discuss how our experience can align with your research goals. We look forward to connecting at the AdvaMed MedTech Conference. Reach out to meet with us during any of the three days. We’re flexible! 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/etMpNdCB 📰 Share TTi's newsletter with your team. https://lnkd.in/eBVHvhst #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #Womenshealth

[⚕️ D-1 | Last chance to register for the AI for Health Summit!] Don’t miss this must-attend health event, tomorrow, November 21st, 2024, co-founded by Artefact and Johnson & Johnson Innovative Medicine France. 🇫🇷 We are particularly honored to announce that the French Minister for Health and Access to Care, Geneviève Darrieussecq, will open this 7th edition with a special address. Note: The Minister's participation is subject to change in case of last-minute scheduling constraints. Join us at STATION F to hear inspiring leaders from the tech and #healthecosystem (major #pharmaceuticalgroups, institutional actors, hospitals, startups, and scale-ups), bringing together key players from both the public and private sectors. 📆 November 21st, 2024 📍 Station F, Paris ➡️ Register here to join 2,000 international participants: https://lnkd.in/ej3pUNa7 🔎 Follow the program and speaker lineup: https://lnkd.in/e-4jBwC8 At the AI for Health Summit 2024, explore exhibits from 39 exhibitors and attend over 80 sessions across 3 stages, focusing on six major themes: ⚙️ #HealthInnovation & Ecosystem 🌍 Population Health Management 📕 (Gen) #AI for Pathologies 💙 Patient Pathway and Quality of Care 🔬 (Gen) AI for #Research 🔎 #DataFoundation and Governance Come listen to over 130 top-tier speakers this Thursday! 🩺 From the #pharmaceutical and #healthcare industry: Johnson & Johnson Innovative Medicine France, Amgen, Biogen, Clariane, Novo Nordisk, Pfizer, Servier, Takeda. 🏛️ From institutions: Anap, ASPIRE, Centre Léon Bérard, EIT Health, French Ministry of Digital Health (Ministère de la Santé), CNAM, Healthcare Data Institute, Agence de l'innovation en santé, Inria, Institut Curie, IUCT-Oncopole (Institut Universitaire du Cancer de Toulouse), numeum, PariSanté Campus, Resah, Unicancer. 🚀 From the Startup and Scale-up ecosystem: Adlin Science, B Consultant, Biolevate, Bioptimus, CODOC, Deemea, Deeplife, Deep Space Biology, DrData, Doctolib, Elixir Health, Emerit Science, ErVimmune, EW2Health, GameAnalyze, GENerX Life, HelloBetter, Iktos, Implicity, Klippa, Kustoma, My S Life, Numind, Octopize, O-KIDIA, Opscidia, Praxy.ai, Pulselife, Qalita, Radiologs, Second Brain, Skezi, Skin Vision, Sparta Care, Synapse Medicine, Tandem Health, Team HART, TraceX, Trustii.io, Use & Share, Whitelab Genomics 🔧 From the Tech ecosystem: Amazon Web Services (AWS), InstaDeep, IQVIA France, Microsoft, MyData-TRUST - Data Protection & Privacy for Life Sciences, Nebius, Pure Storage, Salesforce, Sqilline Health, Theodo HealthTech (ex-Hokla), TriNetX, VIDAL. See you tomorrow!

The #Hackathon4Health is the most important health-themed hackathon in Romania, bringing together brilliant minds to drive innovation in healthcare! Organized by the Carol Davila University of Medicine and Pharmacy through the Centrul de Inovație și e-Health (CieH-UMFCD), this event is powered by collaborations with the Together for Education and Health Foundation, the US Embassy Bucharest, Romania and AmCham Romania. First launched in 2017 by Johnson & Johnson Romania, this hackathon continues growing as a health innovation beacon. What's in store? 📌 Pre-seed Funding: $30,000 for 3 winning teams; 📌 Mentorship: Invaluable guidance from industry leaders, including keynote contributions by Ion-Gheorghe PETROVAI, Innovation Director and Co-Founder of FreshBlood HealthTech - EITHealth RIS Hub for Romania. This edition’s themes: 📌 Prevention and treatment advancements in oncology, hematology, immunology, ophthalmology, and neurology; 📌 Mental health and quality of life improvements; 📌 Medical devices of the future. 🔗 Learn more about Hackathon4Health and how you can join here: hackathon4health.ro

Last week, Reveal HealthTech joined other healthcare leaders at the ViVE 2024 conference in Los Angeles to convene and define the future of healthcare. Here are some of our top highlights from ViVE: 1. Our CEO, Sanchit Mullick, led a panel discussion with Ashok Chennuru, Xavier Avat, Ashish Atreja, MD, MPH, and Sarim Khan about the ability for AI to revolutionize cancer care with leaders from hospitals, payers, and digital health companies 2. We're excited to officially welcome the inaugural cohort of startups in the CancerX Moonshot Accelerator to the program. Over the next few months, we will work alongside other CancerX Accelerator Champions to support these companies and help them scale to have a transformative impact on cancer care 3. We joined ScaleHealth and other digital health innovators in the ScaleHealth Pavilion to discuss opportunities to improve & transform our healthcare system 4. Our team attended several interesting panels during the conference. Some of our favorites included the Nurses ViVE sessions (led by Bonnie Clipper DNP, MA, MBA, RN, CENP, FACHE, FAAN, Brandy Matthews, Michael Hasselberg, and Colin Plover PhD, MSN, MPH, MSEd, RN) and the Payer Insights Program (led by Arundhati Parmar, Shruti Kothari, Dave Sohigian, and Omid Toloui) Check out our latest content for more insights, and stay tuned for upcoming blog posts, webinars, and more: https://lnkd.in/dVZhenCu ViVE Sanchit Mullick Andrew Bravo Beth Wheeler #ViVE2024 #DigitalHealth #HealthInnovation #HealthcareInnovation #FutureOfHealthcare

Interested in #socialmedia in the #respiratoryhealth space? Check out our #ERS2024 report http://dlvr.it/TG9H7R 📥 🚀 Our team monitored and analyzed ERS-related posts on X (previously #Twitter) before, during, and after the event, and here are some key takeaways: 🔍 Key hashtags: The conversation spotlighted #COPD 🫁, #asthma 🫁, #AI 🤖, and #education 🧑🏫 as major areas of focus. 🩺 s related to professional organizations like Asian Pacific Society of Respirology (APSR) and American Thoracic Society were also popular. Top Discussion Themes: #Data dominated discussions 📊, followed by #clinicaltrials 🔬, #education 🧑🏫, #efficacy 💯, #patients 🩺, #congress 🏛️, and #safety ✅. Leading Voices: #Physicians dominated the conversation 🎤, contributing to 56% of posts, followed by #education-related content at 22%. #Researchers 🔬 and #nurses 👩⚕️ each contributed 11%. Audience #Sentiment: The overall sentiment was positive 😄, with #ERS2024 praised for delivering high-quality content that focused on treatment innovations, drug development, clinical trial successes, and new partnerships. However, there were a few constructive points on research methods and treatment accessibility in lower-income regions. Text Analytics: The key discussions zeroed in on #bronchiectasis, #pulmonaryfibrosis, and #COPD, with significant attention on #globalhealth policies and WHO recommendations. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at info@lqventures.com; we cover multiple #therapyareas and events! MENARINI Group AstraZeneca Beijing Rongrui - Century Scie . & Tech.Co ., Ltd. bioMérieux Boehringer Ingelheim Bristol Myers Squibb Celltrion Inc Chiesi Group CSL European Respiratory Society Roche Fujifilm Healthcare Europe Grifols GSK HUNAN BEYOND MEDICAL TECHNOLOGY CO.,LTD Inogen Insmed Incorporated Johnson & Johnson Actelion (now Janssen Pulmonary Hypertension) Medtronic MSD Pfizer Philips ResMed Sanofi Regeneron Thirona Vertex Pharmaceuticals Zambon Verona Pharma #HealthcareConsulting #ERS2024 #SocialListening #DigitalHealth #RespiratoryHealth #MedicalEducation #LucidQuest #CompetitiveMarketing

Interested in #socialmedia in the #respiratoryhealth space? Check out our #ERS2024 report http://dlvr.it/TFZR2t 📥 🚀 Our team monitored and analyzed ERS-related posts on X (previously #Twitter) before, during, and after the event, and here are some key takeaways: 🔍 Key hashtags: The conversation spotlighted #COPD 🫁, #asthma 🫁, #AI 🤖, and #education 🧑🏫 as major areas of focus. 🩺 s related to professional organizations like Asian Pacific Society of Respirology (APSR) and American Thoracic Society were also popular. Top Discussion Themes: #Data dominated discussions 📊, followed by #clinicaltrials 🔬, #education 🧑🏫, #efficacy 💯, #patients 🩺, #congress 🏛️, and #safety ✅. Leading Voices: #Physicians dominated the conversation 🎤, contributing to 56% of posts, followed by #education-related content at 22%. #Researchers 🔬 and #nurses 👩⚕️ each contributed 11%. Audience #Sentiment: The overall sentiment was positive 😄, with #ERS2024 praised for delivering high-quality content that focused on treatment innovations, drug development, clinical trial successes, and new partnerships. However, there were a few constructive points on research methods and treatment accessibility in lower-income regions. Text Analytics: The key discussions zeroed in on #bronchiectasis, #pulmonaryfibrosis, and #COPD, with significant attention on #globalhealth policies and WHO recommendations. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at info@lqventures.com; we cover multiple #therapyareas and events! MENARINI Group AstraZeneca Beijing Rongrui - Century Scie . & Tech.Co ., Ltd. bioMérieux Boehringer Ingelheim Bristol Myers Squibb Celltrion Inc Chiesi Group CSL European Respiratory Society Roche Fujifilm Healthcare Europe Grifols GSK HUNAN BEYOND MEDICAL TECHNOLOGY CO.,LTD Inogen Insmed Incorporated Johnson & Johnson Actelion (now Janssen Pulmonary Hypertension) Medtronic MSD Pfizer Philips ResMed Sanofi Regeneron Thirona Vertex Pharmaceuticals Zambon Verona Pharma #HealthcareConsulting #ERS2024 #SocialListening #DigitalHealth #RespiratoryHealth #MedicalEducation #LucidQuest #CompetitiveMarketing

🏥 NHS agrees to up productivity in return for tech investment 💸 🌐 Embracing technology to drive productivity is a strategic decision aligned with the demands of the digital era. This increase in investment is a necessity in order for the NHS to reach the digital targets it's set for itself. Whether this will all come to fruition and the impact down the line is yet to be seen. ⬇ See the Health Service Journal article below. #healthtech #healthtechnology #healthtechinnovation #nhs #nhsengland #nhsdigital #nhsbudget

⏳ Just 1 day to go until the HealthTech Ireland Innovation Awards! Salaso are honoured to be shortlisted in the Healthcare Collaboration category as a result of our close collaborations with both St James's Hospital Dublin, Ireland, and Northwell Health Cancer Institute in New York, USA, to integrate digital therapy programs into the care pathways for cancer patients. 🌟 The Healthcare Collaboration Award celebrates organisations that excel in fostering collaboration to deliver innovative, safe, and effective healthcare technologies. Salaso’s digital therapy platform enables clinicians to deliver evidence based therapies and patient education to patients. Salaso empowers clinical teams to streamline care delivery and digitally prescribe rehabilitation programs tailored to the patients' needs as part of the of the cancer treatment plan. 💡 Our work with these two cancer centres exemplifies the power of collaboration and knowledge sharing between healthcare providers, technology experts, and patients for successful new service model adoption, and highlights the potential for innovative health technologies and multi-way healthcare collaboration to play a key role in tackling the healthcare crisis. Furthermore, advancements in technology have transformed the extent to which we can work together across borders, making the world a global village where transatlantic collaboration in is more accessible than ever before. The HealthTech Ireland Innovation Awards ceremony will take place tomorrow, Thursday, 21st November, at the Shelbourne Hotel, Dublin. HSE Technology and Transformation Susan Treacy Alison Enright Elaine Brennan Northwell Holdings Enterprise Ireland Enterprise Ireland USA Richard Mulry David Corcoran Jennie Lynch Marisa Spellman Mannion Sandy Dell Fiona Keogan Mary Day niall halliday Meabh Smith Damien McCallion Eileen Bell Julie Bellew Conor Kennedy Bernard Gloster Aoife Ní Mhuirí Gervaise Monks Alexia Sibony #DigitalHealth #HealthTech #HealthcareCollaboration #Innovation #Collaboration #Healthcare #AwardNomination #EmployeeWellbeing #HealthTechIreland #HealthTechInnovationAwards

Interested in #socialmedia in the #respiratoryhealth space? Check out our #ERS2024 report http://dlvr.it/TGHqyK 📥 🚀 Our team monitored and analyzed ERS-related posts on X (previously #Twitter) before, during, and after the event, and here are some key takeaways: 🔍 Key hashtags: The conversation spotlighted #COPD 🫁, #asthma 🫁, #AI 🤖, and #education 🧑🏫 as major areas of focus. 🩺 s related to professional organizations like Asian Pacific Society of Respirology (APSR) and American Thoracic Society were also popular. Top Discussion Themes: #Data dominated discussions 📊, followed by #clinicaltrials 🔬, #education 🧑🏫, #efficacy 💯, #patients 🩺, #congress 🏛️, and #safety ✅. Leading Voices: #Physicians dominated the conversation 🎤, contributing to 56% of posts, followed by #education-related content at 22%. #Researchers 🔬 and #nurses 👩⚕️ each contributed 11%. Audience #Sentiment: The overall sentiment was positive 😄, with #ERS2024 praised for delivering high-quality content that focused on treatment innovations, drug development, clinical trial successes, and new partnerships. However, there were a few constructive points on research methods and treatment accessibility in lower-income regions. Text Analytics: The key discussions zeroed in on #bronchiectasis, #pulmonaryfibrosis, and #COPD, with significant attention on #globalhealth policies and WHO recommendations. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at info@lqventures.com; we cover multiple #therapyareas and events! MENARINI Group AstraZeneca Beijing Rongrui - Century Scie . & Tech.Co ., Ltd. bioMérieux Boehringer Ingelheim Bristol Myers Squibb Celltrion Inc Chiesi Group CSL European Respiratory Society Roche Fujifilm Healthcare Europe Grifols GSK HUNAN BEYOND MEDICAL TECHNOLOGY CO.,LTD Inogen Insmed Incorporated Johnson & Johnson Actelion (now Janssen Pulmonary Hypertension) Medtronic MSD Pfizer Philips ResMed Sanofi Regeneron Thirona Vertex Pharmaceuticals Zambon Verona Pharma #HealthcareConsulting #ERS2024 #SocialListening #DigitalHealth #RespiratoryHealth #MedicalEducation #LucidQuest #CompetitiveMarketing